Catalyst Private Wealth
PFE icon

Catalyst Private Wealth’s Pfizer PFE Stock Holding History

Catalyst Private Wealth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$260K Buy
+9,112
New +$242K 0.11% 83
2020
Q4 		– Sell
-268
Closed -$9K – 215
2020
Q3 		$9K Buy
+268
New +$9.4K 0.01% 217

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Catalyst Private Wealth's PFE Position: Q3 2026 in Review

Catalyst Private Wealth opened a new position in Pfizer (PFE) in Q3 2026: 9,112 shares worth $260K. The stake represents 0.11% of the portfolio and ranks #83 among its holdings. This is a return to the name: Catalyst Private Wealth previously reported a position in PFE as recently as Q3 2020.

Catalyst Private Wealth first reported a position in PFE in Q3 2020 and has held it in 2 quarters since. 1,268 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Catalyst Private Wealth held 9,112 shares of Pfizer worth $260K as of Q3 2026.
  • Pfizer was a new Catalyst Private Wealth position in Q3 2026.
  • Pfizer made up 0.11% of Catalyst Private Wealth's portfolio in Q3 2026, its #83 holding.
  • Catalyst Private Wealth first reported a position in Pfizer in Q3 2020 and has held it in 2 quarters since.
  • 1,268 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Catalyst Private Wealth's 13F filing for Q3 2026, filed 13 Oct 2026.